UPDATE - Oppenheimer Upgraded Chemtura Corporation (CHMT) to Outperform; All The Way to $60
Tweet Send to a FriendGet Alerts CHMT Hot Sheet
Price: $23.95 +3.81%
Rating Summary:
5 Buy, 1 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 11 | Down: 35 | New: 23
Rating Summary:
5 Buy, 1 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 11 | Down: 35 | New: 23
Trade CHMT Now!
UPDATE - Oppenheimer upgraded Chemtura Corporation (NYSE: CHMT) from Market Perform to Outperform with a new price target of $21.00.
Oppenheimer analyst said, "We upgrade CHMT as its long restructuring post-bankruptcy takes hold, 4Q's margin expansion looks to have legs, and the rebound in electronics flame retardants, its most profitable segment, is faster than expected. We raise our '12E EPS to $1.22, '13E to $1.72, and implement a 12-18 month $21 price target (12x '13E P/E, 5.3x FV/EBITDA, 10% FCF yield). However, if CHMT can execute on its ambitious long-term objectives, a stretch, but now not wholly implausible, its shares could ultimately work toward the $60s range."
To see more ratings on CHMT, Click Here
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Oppenheimer analyst said, "We upgrade CHMT as its long restructuring post-bankruptcy takes hold, 4Q's margin expansion looks to have legs, and the rebound in electronics flame retardants, its most profitable segment, is faster than expected. We raise our '12E EPS to $1.22, '13E to $1.72, and implement a 12-18 month $21 price target (12x '13E P/E, 5.3x FV/EBITDA, 10% FCF yield). However, if CHMT can execute on its ambitious long-term objectives, a stretch, but now not wholly implausible, its shares could ultimately work toward the $60s range."
To see more ratings on CHMT, Click Here
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Topeka Capital Starts Laredo Petroleum (LPI) at Buy, Assets 'Undervalued'
- UBS Starts Regeneron Pharma (REGN) at Neutral
- Barclays Starts T-Mobile US, (TMUS) at Equalweight
Create E-mail Alert Related Categories
New CoverageRelated Entities
Bankruptcy
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
